Safety and Efficacy of MRI-Based Thrombolysis in Unclear-Onset Stroke


Phase N/A Results

Trial Description

To report the preliminary data on the safety and efficacy of MRI-based thrombolysis in UnCLOS patients.


Trial Design

Retrospective data analysis

Patient Involvement

Subjects received thrombolysis with IV tPA or combined IV tPA and IA urokinase within 3 hours of onset or IA urokinase within 6 hours from symptom detection. Rates of immediate and 5-day recanalization, early neurological improvement and symptomatic intracranial hemorrhage within 48 h after treatment and 3-month mRS were compared between patients with UnCLOS and those with clear-onset stroke (CLSO).


Type Measure Time Frame Safety Issue
No outcomes associated with this trial.


Grant (A050586) of the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea.